Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review

When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.

Detalles Bibliográficos
Autores principales: Ata, Fateen, Akkam Veettil, Safna Farsana, Gaber, Mohammed, Omar, Nabil E., Madani, Ammar, Mah. Afifi, Hebatalla, Aldardouri, Meeloud M., Amer, Aliaa, Kohla, Samah, Zar Gul, Abdul Rehman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981661/
https://www.ncbi.nlm.nih.gov/pubmed/33768906
http://dx.doi.org/10.1002/ccr3.3860
Descripción
Sumario:When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.

Ejemplares similares